In vitro structure–activity relationship of Re-cyclized octreotide analogues
- 31 July 2010
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 37 (5) , 527-537
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Somatostatin Receptor-Binding Peptides Suitable for Tumor Radiotherapy with Re-188 or Re-186. Chemistry and Initial Biological StudiesJournal of Medicinal Chemistry, 2007
- Novel sst2-Selective Somatostatin Agonists. Three-Dimensional Consensus Structure by NMRJournal of Medicinal Chemistry, 2006
- Radioiodination of Rhenium Cyclized α-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in MelanomaCancer Research, 2004
- Radiochemical Investigations of 99mTc−N3S-X-BBN[7−14]NH2: An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering MoietiesBioconjugate Chemistry, 2002
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Synthesis and Characterization of Rhenium-Complexed α-Melanotropin AnalogsBioconjugate Chemistry, 1997
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995
- 1H, 13C and 15N chemical shift referencing in biomolecular NMRJournal of Biomolecular NMR, 1995
- Conformation of two somatostatin analogues in aqueous solutionEuropean Journal of Biochemistry, 1989
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982